source
- Yale and Harvard faculty question benefits of FDA's 'America First' user fee provisionsYale and Harvard medical school faculty have voiced concerns about the latest FDA user fee agreement, which includes a set of "America First" provisions. The provisions are designed to prioritize…
- Novartis to pay $125M for blood-brain barrier crossing platformProceeds from the deal, which hands Novartis global rights to a technology developed by Sironax, will help advance three candidates that the startup says have “best-in-class” potential.BioPharma Dive · 1mo ago↗ source